Health
Chinese-developed inactivated vaccine has low rate of adverse reactions – Global Times
A Chinese-developed inactivated COVID-19 vaccine on Thursday revealed a low rate of adverse reactions for patients in phase one and two clinical trials while also demonstrating immunogenicity results. The interim analysis of two randomized clinical trials sug…
vaccine Photo:VCG
A Chinese-developed inactivated COVID-19 vaccine on Thursday revealed a low rate of adverse reactions for patients in phase one and two clinical trials while also demonstrating immunogenicity results. The interim analysis of two randomized clinical trials suggests a relatively better safety profile compared with other kinds of the same type of vaccine, researchers said in the latest report.The report, published in peer-reviewed medical journal The Journal of the American Medic…
-
Business21 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News21 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
General8 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
General8 hours agoAsia stocks plunge, HK suffers steepest fall since 1997